http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106619481-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2016-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106619481-B |
| titleOfInvention | Long-acting 5-HT1A receptor agonist and preparation method thereof |
| abstract | The invention discloses a tamsulosin citrate sustained release preparation with 5-HT1A receptor agonism and a preparation method thereof, wherein the preparation comprises a certain proportion of tamsulosin citrate, a hydrophilic gel material and a waxy material, and a proper amount of filler and lubricant are added. The sustained release preparation has the function of maintaining the sustained release for 24 hours, has no sudden release risk during the drug release period, good drug release uniformity, simple preparation process and strong process controllability, can avoid overlarge blood concentration fluctuation after being taken, and improves the safety, effectiveness and compliance of medication. |
| priorityDate | 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.